Charles Schwab Investment Management Inc. Buys 11,999 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Charles Schwab Investment Management Inc. boosted its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 1.0% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,203,676 shares of the company’s stock after purchasing an additional 11,999 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Henry Schein were worth $82,440,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Farther Finance Advisors LLC increased its holdings in Henry Schein by 237.3% in the first quarter. Farther Finance Advisors LLC now owns 2,698 shares of the company’s stock valued at $186,000 after purchasing an additional 1,898 shares during the last quarter. State of Alaska Department of Revenue increased its holdings in Henry Schein by 2.8% in the first quarter. State of Alaska Department of Revenue now owns 14,611 shares of the company’s stock valued at $1,000,000 after purchasing an additional 395 shares during the last quarter. Oppenheimer Asset Management Inc. increased its holdings in Henry Schein by 5.2% in the first quarter. Oppenheimer Asset Management Inc. now owns 13,745 shares of the company’s stock valued at $941,000 after purchasing an additional 678 shares during the last quarter. GAMMA Investing LLC increased its holdings in Henry Schein by 37.8% in the first quarter. GAMMA Investing LLC now owns 3,939 shares of the company’s stock valued at $270,000 after purchasing an additional 1,081 shares during the last quarter. Finally, Natixis Advisors LLC increased its holdings in Henry Schein by 5.2% in the first quarter. Natixis Advisors LLC now owns 11,508 shares of the company’s stock valued at $788,000 after purchasing an additional 572 shares during the last quarter. Institutional investors own 96.62% of the company’s stock.

Henry Schein Stock Up 2.2%

HSIC stock opened at $68.99 on Thursday. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.41 and a quick ratio of 0.78. The stock has a market capitalization of $8.37 billion, a P/E ratio of 22.25, a P/E/G ratio of 2.23 and a beta of 0.81. The business has a 50-day moving average of $70.91 and a 200-day moving average of $70.96. Henry Schein, Inc. has a fifty-two week low of $60.56 and a fifty-two week high of $82.49.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $1.10 earnings per share for the quarter, missing the consensus estimate of $1.19 by ($0.09). The firm had revenue of $3.24 billion for the quarter, compared to analyst estimates of $3.22 billion. Henry Schein had a return on equity of 14.36% and a net margin of 3.05%. The firm’s quarterly revenue was up 3.3% on a year-over-year basis. During the same period in the prior year, the company earned $1.23 earnings per share. On average, sell-side analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

HSIC has been the subject of a number of recent analyst reports. Wells Fargo & Company dropped their price objective on Henry Schein from $80.00 to $75.00 and set an “equal weight” rating for the company in a report on Tuesday, May 6th. UBS Group lowered their price target on Henry Schein from $75.00 to $70.00 and set a “neutral” rating for the company in a report on Wednesday, August 6th. Baird R W downgraded Henry Schein from a “strong-buy” rating to a “hold” rating in a report on Monday, July 14th. Wall Street Zen downgraded Henry Schein from a “buy” rating to a “hold” rating in a report on Thursday, April 17th. Finally, Barrington Research lowered their price target on Henry Schein from $86.00 to $78.00 and set an “outperform” rating for the company in a report on Wednesday, August 6th. Nine research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $75.58.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.